The DIFA Partner Program was developed to enhance and complement the increasingly complex media ecosystem. By bringing direct feeds of media exposure data into the DIFA platform, the DIFA Partner Program eliminates the dependency on the current mechanism of third-party cookies for digital measurement. These direct integrations will also improve media measurement by capturing data on the exposed audience more completely and holistically, across browsers and devices.
The DIFA Partner Program can measure both traditional and non-traditional media channels. Crossix has established relationships with more than 30 partners, including leading brands in digital connected TV, linear TV, over-the-top TV, digital, audio, radio, mobile applications, endemic, out of home, print, and email.
“We are committed to a modern, privacy-first approach to audience targeting and measurement,” said Asaf Evenhaim, CEO and Co-founder of Crossix. “The DIFA Partner program is one of several initiatives at Crossix designed to address ongoing changes in the media ecosystem.”
"LiveIntent built its identity framework to bridge the ecosystem to the first-party data that Publishers and Brands have uniquely amassed by virtue of their content and loyalty,” said Brian Silver, President, LiveIntent. “That bridge will be the key to having our clients complement their traditional measurement tactics with DIFA in order to measure success both in the present, and for a future where the third-party cookie is no longer available,” added Kelly Hogue, VP, Programmatic and Strategic Partnerships, LiveIntent.
Learn more about the future development of the Crossix DIFA Platform at Veeva Commercial & Medical Summit on June 9-10, 2020. Register for the online event and stay up-to-date on program details at Crossix.com/summit.
About Crossix Solutions, A Veeva Company
A pioneer in patient data, privacy, and analytics, Crossix leverages the industry’s most advanced technology to connect comprehensive health and non-health data, covering more than 300 million lives – all in a privacy-safe way. It delivers data and insights to over 200 brands from top 20 pharma companies as well as leading health systems, pharmacies, and wellness brands. For more information, visit crossix.com.
This release contains forward-looking statements, including expectations regarding the market demand for and acceptance of the data, analytics, software solutions, and services offered by Crossix, a Veeva company, and the results and benefits from use of such offerings. Any forward-looking statements contained in this press release are based upon Crossix’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Crossix’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Crossix and Veeva disclaim any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially, including whether demand for Crossix’s offerings will grow as anticipated; the competitive environment in the industry; and general market and business conditions (including the on-going impact of COVID-19). Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in Veeva’s filing on Form 10-Q for the period ended April 30, 2020. This is available on the company’s website at veeva.com under the Investors section and on the SEC’s website at sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.